Assay To Measure Pct To Aid In The Risk Assessment Of Critically Ill Patients On Their First Day Of Icu Admission
PTF is the FDA product code for Assay To Measure Pct To Aid In The Risk Assessment Of Critically Ill Patients On Their First Day Of Icu Admission, a class II device type, regulated under 21 CFR 866.3215. FDA's definition for this code reads: "Assay to measure procalcitonin to aid in the risk assessment of critically ill patients on their first day of ICU admission for progression to severe sepsis and septic shock". As of , FDA records hold 4 510(k) clearances under this code, the most recent dated , and one recall.
Classification record
- Product code
- PTF
- Device name
- Assay To Measure Pct To Aid In The Risk Assessment Of Critically Ill Patients On Their First Day Of Icu Admission
- FDA definition
- Assay to measure procalcitonin to aid in the risk assessment of critically ill patients on their first day of ICU admission for progression to severe sepsis and septic shock
- Regulation
- 21 CFR 866.3215
- Device class
- Class II
- Review panel
- Microbiology
- Submission type
- 510(k)
- Implant
- No
- Life sustaining or supporting
- No
- GMP exempt
- No
- Third party review eligible
- No
- Ingested clearances
- 4
- Ingested recalls
- 1
Clearances, product code PTF
By decision yearShow the numbers
| Year | Clearances |
|---|---|
| 2017 | 1 |
| 2019 | 1 |
| 2023 | 1 |
| 2025 | 1 |
Applicants with the most clearances
Product code PTF| Applicant | Clearances |
|---|---|
| Siemens Healthcare Diagnostics Inc. | 2 |
| Diasys Diagnostic Systems GmbH | 1 |
| Diazyme Laboratories, Inc. | 1 |
Companies listing this code with FDA
Companies whose registered establishments list this codeFIRST ARTICLE / WEEKLY
What cleared, what was recalled, and what changed in the standards. One edition a week for the people who make medical devices.
